Association of both consistency and strength of self-reported clinician recommendation for HPV vaccination and HPV vaccine uptake among 11- to 12-year-old children
- PMID: 28958810
- PMCID: PMC5641254
- DOI: 10.1016/j.vaccine.2017.09.056
Association of both consistency and strength of self-reported clinician recommendation for HPV vaccination and HPV vaccine uptake among 11- to 12-year-old children
Abstract
Purpose: We tested the hypotheses that consistency and strength of clinician recommendation of the human papillomavirus (HPV) vaccination would be associated with vaccine delivery rates.
Methods: From October 2015 through January 2016, we conducted a survey of primary care clinicians (n=227) in Southeastern Minnesota to evaluate clinician behaviors regarding HPV vaccination. The survey response rate was 41.0% (51 clinical sites). We used the Rochester Epidemiology Project, a clinical data linkage infrastructure, to ascertain clinical site-level HPV vaccination rates. We examined associations of clinician self-reports of both the consistency and strength of their recommendations for HPV vaccination for patients aged 11-12years (n=14,406) with site-level vaccination rates.
Results: The majority of clinicians reported consistently (always or usually) recommending the HPV vaccine to females (79.0%) and to males (62.2%); 71.9% of clinicians reported strongly recommending the vaccine to females while 58.6% reported strongly recommending to males. Consistency and strength of recommending the HPV vaccine was significantly higher among those practicing in pediatrics and board certified in pediatrics compared to family medicine. Higher rates of initiation (1 dose) [Incidence Rate Ratio (IRR)=1.05; 95% CI (1.01-1.09)] and completion (3 doses) [IRR=1.08; 95% CI (1.02-1.13)] were observed among clinical sites where, on average, clinicians more frequently reported always or usually recommending the vaccine for females compared to sites where, on average, clinicians reported recommending the vaccine less frequently. Similarly, higher rates of initiation [IRR=1.03; 95% CI (1.00-1.06)] and completion [IRR=1.04; CI (1.00, 1.08)] were observed among sites where clinicians reported strongly recommending the vaccine to females more frequently compared to sites where, on average, clinicians reported strongly recommending the HPV vaccine less frequently; similar associations were observed for male initiation [IRR=1.05; CI (1.02,1.08)] and completion [IRR=1.05; 95% CI (1.01, 1.09)].
Conclusions: Consistency and strength of HPV vaccination recommendation was associated with higher vaccination rates.
Keywords: Guideline adherence; Papillomavirus vaccines health knowledge, attitudes, practice; Patient acceptance of health care; Professional practice; Vaccination; Vaccination refusal.
Copyright © 2017 Elsevier Ltd. All rights reserved.
Similar articles
-
Clinician knowledge, clinician barriers, and perceived parental barriers regarding human papillomavirus vaccination: Association with initiation and completion rates.Vaccine. 2017 Jan 3;35(1):164-169. doi: 10.1016/j.vaccine.2016.11.012. Epub 2016 Nov 23. Vaccine. 2017. PMID: 27887795 Free PMC article.
-
Missing the Target for Routine Human Papillomavirus Vaccination: Consistent and Strong Physician Recommendations Are Lacking for 11- to 12-Year-Old Males.Cancer Epidemiol Biomarkers Prev. 2016 Oct;25(10):1435-1446. doi: 10.1158/1055-9965.EPI-15-1294. Epub 2016 Aug 2. Cancer Epidemiol Biomarkers Prev. 2016. PMID: 27486020 Free PMC article.
-
HPV vaccine recommendation profiles among a national network of pediatric practitioners: understanding contributors to parental vaccine hesitancy and acceptance.Hum Vaccin Immunother. 2019;15(7-8):1776-1783. doi: 10.1080/21645515.2018.1560771. Epub 2019 Jan 30. Hum Vaccin Immunother. 2019. PMID: 30570419 Free PMC article.
-
US Health Care Clinicians' Knowledge, Attitudes, and Practices Regarding Human Papillomavirus Vaccination: A Qualitative Systematic Review.Acad Pediatr. 2018 Mar;18(2S):S53-S65. doi: 10.1016/j.acap.2017.10.007. Acad Pediatr. 2018. PMID: 29502639 Free PMC article.
-
Disparities in Healthcare Providers' Recommendation of HPV Vaccination for U.S. Adolescents: A Systematic Review.Cancer Epidemiol Biomarkers Prev. 2021 Nov;30(11):1981-1992. doi: 10.1158/1055-9965.EPI-21-0733. Epub 2021 Aug 23. Cancer Epidemiol Biomarkers Prev. 2021. PMID: 34426414 Free PMC article.
Cited by
-
The Effect of Clinical Decision Prompts in Improving Human Papillomavirus Vaccination Rates in a Multispecialty Practice in a Predominantly Hispanic Population: Quasi-Experimental Study.JMIR Cancer. 2023 Mar 15;9:e42890. doi: 10.2196/42890. JMIR Cancer. 2023. PMID: 36920453 Free PMC article.
-
Coaching and Communication Training for HPV Vaccination: A Cluster Randomized Trial.Pediatrics. 2022 Aug 1;150(2):e2021052351. doi: 10.1542/peds.2021-052351. Pediatrics. 2022. PMID: 35818840 Free PMC article. Clinical Trial.
-
Identifying and supporting vaccine champions in pediatric primary care: a qualitative interview study.Transl Behav Med. 2024 Nov 25;14(12):722-731. doi: 10.1093/tbm/ibae054. Transl Behav Med. 2024. PMID: 39402839 Free PMC article.
-
Effect of provider recommendation style on the length of adolescent vaccine discussions.Vaccine. 2021 Feb 5;39(6):1018-1023. doi: 10.1016/j.vaccine.2020.11.015. Epub 2021 Jan 12. Vaccine. 2021. PMID: 33446387 Free PMC article.
-
How health care providers should address vaccine hesitancy in the clinical setting: Evidence for presumptive language in making a strong recommendation.Hum Vaccin Immunother. 2020 Sep 1;16(9):2131-2135. doi: 10.1080/21645515.2020.1735226. Epub 2020 Apr 3. Hum Vaccin Immunother. 2020. PMID: 32242766 Free PMC article.
References
-
- Viens LJ, et al. Human papillomavirus-associated cancers - United States, 2008–2012. MMWR Morb Mortal Wkly Rep. 2016;65(26):661–6. - PubMed
-
- Markowitz LE, et al. Quadrivalent human papillomavirus vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP) Morbidity & Mortality Weekly Report Recommendations & Reports. 2007;56(RR-2):1–24. - PubMed
-
- Recommendations on the use of quadrivalent human papillomavirus vaccine in males--Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morbidity and mortality weekly report. 2011;60(50):1705–8. - PubMed
-
- Reagan-Steiner S, et al. National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years - United States, 2015. MMWR Morb Mortal Wkly Rep. 2016;65(33):850–8. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical